Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,284 public trials 1,281 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Recruiting

Safety and Efficacy of OBX-115 in Advanced Solid Tumors

NCT06060613

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +23 more
Locations
  • The Angeles Clinic and Research Institute (Melanoma) Los Angeles, California, United States
  • USC Norris Comprehensive Cancer Center (Melanoma/NSCLC) Los Angeles, California, United States
  • Stanford Cancer Institute (Melanoma/NSCLC) Stanford, California, United States
  • Orlando Health Cancer Institute (Melanoma/NSCLC) Orlando, Florida, United States
View Trial Details
Recruiting

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

NCT05652686

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +22 more
Locations
  • City of Hope (City of Hope National Medical Center, City of Hope Medical Center) Duarte, California, United States
  • USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Sarah Cannon Research Institute at HealthONE Denver, Colorado, United States
  • Yale University Cancer Center New Haven, Connecticut, United States
View all 15 locations
View Trial Details
Recruiting

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

NCT05432804

Conditions
Astrocytoma, Glioblastoma, Glioma, +9 more
Locations
  • Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • Keck Medicine of USC Koreatown Los Angeles, California, United States
View all 36 locations
View Trial Details
Recruiting

Anti-GD2 ADC M3554 in Advanced Solid Tumors

NCT06641908

Conditions
Advanced Solid Tumor, Astrocytoma, Glioblastoma, +10 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Memorial Sloan-Kettering Cancer Center (MSKCC) - New York - Memorial Sloan Kettering Cancer Center (CC)- Westc New York, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • UZ Leuven Leuven, Belgium
View Trial Details
Recruiting

Study of AMXT 1501 and DFMO in Combination With Standard Therapies in Advanced Solid Tumors

NCT07287917

Conditions
Breast Diseases, Breast Neoplasms, HER2-low Hormone Receptor Positive Breast Cancer, +13 more
Locations
  • University of Arizona Tucson, Arizona, United States
  • START Los Angeles Los Angeles, California, United States
  • Skin Cancer Institute Englewood, Colorado, United States
  • Wayne State University - Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View all 17 locations
View Trial Details

Related conditions